As of March 31, 2024
Name
Kanzawa Medical Research Foundation
Competent government
Cabinet Office
Established
June 27, 1997
July 1st, 2010 (transition to a public interest foundation)
July 1st, 2010 (transition to a public interest foundation)
Contributors
Kunio Kanzawa, Kissei Pharmaceutical Co., Ltd.
History of establishment
Established on the basis of private assets offered by Kunio Kanzawa,
Chairman of Kissei Pharmaceutical Co., Ltd. and funds provided
by Kissei Pharmaceutical Co., Ltd. in commemoration of its 50th anniversary
in business.
Basis assets
2,265,840,571JPY As of March 31, 2024
Purpose of establishment
Promote development of healthcare and medical science by encouraging studies (hereinafter referred to as subjected studies) from various angles on causes,
prevention, diagnoses, therapies, etc. of various diseases occurred in women at reproductive age with focus on perinatal period and elderly/senile women,
thereby contributing to enhancement of the people’s health and welfare.
Description of business
The following business is conducted to achieve the purpose.
- Award excellent research results on the subjected studies
- Research grants to subjected studies
- Overseas study grants on subjected studies
- Organize seminars on subjected studies
Research award/
Subsidiary plan
Subsidiary plan
Kanzawa Medical Award (Research Award):
5 million yen per study For one person
Research grants:
2.5 million yen per study For 10 persons
Overseas study grants:
1 million yen per study For 4 persons
5 million yen per study For one person
Research grants:
2.5 million yen per study For 10 persons
Overseas study grants:
1 million yen per study For 4 persons